The influence of metabolic syndrome on the risk of hepatocellular carcinoma in patients with chronic hepatitis B infection in mainland China
Cancer Epidemiology, Biomarkers & Prevention Nov 14, 2019
Tan Y, Zhang X, Zhang W, et al. - Researchers investigated the potential link between hepatocellular carcinoma (HCC) risk and metabolic syndrome (MS) among prospectively enrolled 6,564 people with hepatitis B virus (HBV) infection from an initial cohort of 105,397 civil servants in mainland China. They used Cox proportional hazards models to assess multivariate-adjusted HR and 95% confidence interval. They used Kaplan–Meier curves to plot cumulative incidences. A 45,668.0 person-year follow-up (76.0 ± 30.8 months) was performed in 6,564 individuals who were seropositive for hepatitis B surface antigen. After follow-up, they detected 89 incident HCC cases. Independent link of MS, as a whole, with a 2-fold increased HCC risk was revealed after adjusting for age (in 1-year increments), gender, cigarette smoking, alcohol intake, liver cirrhosis, and elevated aspartate aminotransferase levels (≥ 40 U/L). In this study, the independent links of MS as a whole, central obesity, and type 2 diabetes, with increased HCC risk were shown in individuals with HBV infection in mainland China.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries